297 related articles for article (PubMed ID: 18789686)
21. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Shin D; Lee SC; Heo YS; Lee WY; Cho YS; Kim YE; Hyun YL; Cho JM; Lee YS; Ro S
Bioorg Med Chem Lett; 2007 Oct; 17(20):5686-9. PubMed ID: 17764934
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of analogues of the anti-tumor alkaloid naamidine A.
Aberle N; Catimel J; Nice EC; Watson KG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3741-4. PubMed ID: 17462892
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors.
Chen S; Chen L; Le NT; Zhao C; Sidduri A; Lou JP; Michoud C; Portland L; Jackson N; Liu JJ; Konzelmann F; Chi F; Tovar C; Xiang Q; Chen Y; Wen Y; Vassilev LT
Bioorg Med Chem Lett; 2007 Apr; 17(8):2134-8. PubMed ID: 17303421
[TBL] [Abstract][Full Text] [Related]
26. A facile solid-phase synthesis of 1,2,4,5-tetrasubstituted imidazoles using sodium benzenesulfinate as a traceless linker.
Li W; Lam Y
J Comb Chem; 2005; 7(5):644-7. PubMed ID: 16153057
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-beta type1 receptor kinase inhibitors.
Kim DK; Choi JH; An YJ; Lee HS
Bioorg Med Chem Lett; 2008 Mar; 18(6):2122-7. PubMed ID: 18262787
[TBL] [Abstract][Full Text] [Related]
28. 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase.
Alexander R; Balasundaram A; Batchelor M; Brookings D; Crépy K; Crabbe T; Deltent MF; Driessens F; Gill A; Harris S; Hutchinson G; Kulisa C; Merriman M; Mistry P; Parton T; Turner J; Whitcombe I; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(15):4316-20. PubMed ID: 18625552
[TBL] [Abstract][Full Text] [Related]
29. A series of ethyl 6-arylmethoxy-7-alkoxy-4-hydroxy-3-quinolinecarboxylates: synthesis and anticoccidial activity against Eimeria tenella.
Yan CR; Xu J; Weng YB; Li J; Wang YL; Chen H
Chem Biol Drug Des; 2008 Oct; 72(4):314-9. PubMed ID: 18793306
[TBL] [Abstract][Full Text] [Related]
30. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.
Andreani A; Burnelli S; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Rizzoli M; Varoli L; Roda A
Eur J Med Chem; 2008 Mar; 43(3):657-61. PubMed ID: 17624631
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
Laufer SA; Hauser DR; Domeyer DM; Kinkel K; Liedtke AJ
J Med Chem; 2008 Jul; 51(14):4122-49. PubMed ID: 18578517
[TBL] [Abstract][Full Text] [Related]
32. Optimization of triarylimidazoles for Tie2: influence of conformation on potency.
Johnson NW; Semones M; Adams JL; Hansbury M; Winkler J
Bioorg Med Chem Lett; 2007 Oct; 17(20):5514-7. PubMed ID: 17826092
[TBL] [Abstract][Full Text] [Related]
33. 4-Aminothiazolyl analogs of GE2270 A: design, synthesis and evaluation of imidazole analogs.
LaMarche MJ; Leeds JA; Dzink-Fox J; Mullin S; Patane MA; Rann EM; Tiamfook S
Bioorg Med Chem Lett; 2011 Jun; 21(11):3210-5. PubMed ID: 21550238
[TBL] [Abstract][Full Text] [Related]
34. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Vu CB; Bemis JE; Disch JS; Ng PY; Nunes JJ; Milne JC; Carney DP; Lynch AV; Smith JJ; Lavu S; Lambert PD; Gagne DJ; Jirousek MR; Schenk S; Olefsky JM; Perni RB
J Med Chem; 2009 Mar; 52(5):1275-83. PubMed ID: 19199480
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of imidazo[2,1-b]thiazoles and thiazolines as potential antiulcer agents.
Andreani A; Rambaldi M; Leoni A; Locatelli A; Pifferi G
J Pharm Belg; 1994; 49(4):308-14. PubMed ID: 7965580
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel, selective and potent Chk2 inhibitors.
Larson G; Yan S; Chen H; Rong F; Hong Z; Wu JZ
Bioorg Med Chem Lett; 2007 Jan; 17(1):172-5. PubMed ID: 17035018
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anthelmintic activity of carbamates derived from imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b]thiazole.
Marin A; Valls N; Berenguer FJ; Alonso MT; Ramon Martinez A; Mercedes Martinez M; Elguero J
Farmaco; 1992 Jan; 47(1):63-75. PubMed ID: 1616578
[TBL] [Abstract][Full Text] [Related]
38. Imidazothiazole and related heterocyclic systems. Synthesis, chemical and biological properties.
Fascio ML; Errea MI; D'Accorso NB
Eur J Med Chem; 2015 Jan; 90():666-83. PubMed ID: 25499987
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of the anticoccidial activity of trifluoropyrido[1,2-a]pyrimidin-2-one derivatives.
Silpa L; Niepceron A; Laurent F; Brossier F; Pénichon M; Enguehard-Gueiffier C; Abarbri M; Silvestre A; Petrignet J
Bioorg Med Chem Lett; 2016 Jan; 26(1):114-20. PubMed ID: 26597537
[TBL] [Abstract][Full Text] [Related]
40. Anticoccidial activity of alborixin.
Folz SD; Nowakowski LH; Lee BL; Conder GA; Rector DL; Brodasky TF
J Parasitol; 1987 Feb; 73(1):29-35. PubMed ID: 3572663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
